BTAI BioXcel Therapeutics, Inc.
Healthcare$1.22+7.96%ClosedMarket Cap: $37.7M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
8
Dispositions
12
Buy/Sell Ratio
0.67
Net Shares
-39,669
Shares Acquired
147,258
Shares Disposed
186,927
Total Bought ($)
$0.00
Total Sold ($)
$4.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Fri May 22 | Yocca Frank | officer: Chief Scientific Officer | Sell | 6,845 | $1.09 | 26,175 |
| Fri May 22 | Yocca Frank | officer: Chief Scientific Officer | Sell | 17,500 | $0.00 | 52,500 |
| Fri May 22 | Steinhart Richard I | officer: Chief Financial Officer | Sell | 6,845 | $1.09 | 26,300 |
| Fri May 22 | Steinhart Richard I | officer: Chief Financial Officer | Sell | 17,500 | $0.00 | 52,500 |
| Fri May 22 | Rodriguez Javier | officer: See Remarks | Sell | 6,560 | $1.08 | 26,803 |
| Fri May 22 | Rodriguez Javier | officer: See Remarks | Sell | 17,500 | $0.00 | 52,500 |
| Fri May 22 | Mehta Vimal | director, officer: CEO and President | Sell | 49,758 | $0.00 | 149,274 |
| Thu May 07 | Yocca Frank | officer: Chief Scientific Officer | Sell | 9,000 | $0.00 | 15,520 |
| Thu May 07 | Steinhart Richard I | officer: Chief Financial Officer | Sell | 9,000 | $0.00 | 15,645 |
| Thu May 07 | Rodriguez Javier | officer: See Remarks | Sell | 9,000 | $0.00 | 15,863 |
| Thu May 07 | Mehta Vimal | director, officer: CEO and President | Sell | 18,000 | $0.00 | 39,259 |
| Mon Mar 16 | Steinhart Richard I | officer: Chief Financial Officer | Sell | 35 | $0.00 | 6,645 |
| Mon Mar 16 | Steinhart Richard I | officer: Chief Financial Officer | Sell | 33 | $0.00 | 6,610 |
| Mon Mar 16 | Rodriguez Javier | officer: See Remarks | Sell | 35 | $0.00 | 6,863 |
| Mon Mar 16 | Rodriguez Javier | officer: See Remarks | Sell | 33 | $0.00 | 6,828 |